Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 839

1.

Second primary cancers in long-term survivors of glioblastoma.

Kim JY, Jackman JG, Woodring S, McSherry F, Herndon JE, Desjardins A, Friedman HS, Peters KB.

Neurooncol Pract. 2019 Sep;6(5):386-391. doi: 10.1093/nop/npz001. Epub 2019 Feb 4.

PMID:
31555453
2.

IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.

Li Q, Chen Y, Zhang D, Grossman J, Li L, Khurana N, Jiang H, Grierson PM, Herndon J, DeNardo DG, Challen GA, Liu J, Ruzinova MB, Fields RC, Lim KH.

JCI Insight. 2019 Oct 3;4(19). pii: 130867. doi: 10.1172/jci.insight.130867.

3.

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Patel MP, Woodring S, Randazzo DM, Friedman HS, Desjardins A, Healy P, Herndon JE 2nd, McSherry F, Lipp ES, Miller E, Peters KB, Affronti ML.

Support Care Cancer. 2019 Aug 22. doi: 10.1007/s00520-019-05039-x. [Epub ahead of print]

PMID:
31440823
4.

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Boulton S, Desjardins A, Ashley DM, Friedman HS, Peters KB.

Complement Ther Clin Pract. 2019 Aug;36:43-48. doi: 10.1016/j.ctcp.2019.05.002. Epub 2019 May 18.

PMID:
31383442
5.

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaau9240. doi: 10.1126/scitranslmed.aau9240.

PMID:
31270275
6.

ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma.

Tsvankin V, Hashizume R, Katagi H, Herndon JE, Lascola C, Venkatraman TN, Picard D, Burrus B, Becher OJ, Thompson EM.

Neurosurgery. 2019 Jun 21. pii: nyz212. doi: 10.1093/neuros/nyz212. [Epub ahead of print]

PMID:
31225627
7.

Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice.

Desjardins A, Herndon JE 2nd, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Sampson JH, Randazzo D, Sommer N, Friedman AH, Friedman HS.

Health Sci Rep. 2019 Feb 13;2(4):e114. doi: 10.1002/hsr2.114. eCollection 2019 Apr.

8.

MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.

Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, Moure CJ, Hemphill C, Carpenter AB, Healy P, Ruger RC, Chen CJ, Greer PK, Zhao F, Spasojevic I, Grenier C, Huang Z, Murphy SK, McLendon RE, Friedman HS, Friedman AH, Herndon JE 2nd, Sampson JH, Keir ST, Bigner DD, Yan H, He Y.

Cancer Res. 2019 Jul 1;79(13):3383-3394. doi: 10.1158/0008-5472.CAN-18-1010. Epub 2019 Apr 30.

PMID:
31040154
9.

Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE.

Nat Med. 2019 Mar;25(3):529. doi: 10.1038/s41591-019-0355-0.

PMID:
30670876
10.

Dental quality measures.

Herndon JB, Amundson CW.

J Am Dent Assoc. 2019 Jan;150(1):4. doi: 10.1016/j.adaj.2018.11.016. No abstract available.

PMID:
30611324
11.

MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.

Lipp ES, Healy P, Austin A, Clark A, Dalton T, Perkinson K, Herndon JE, Friedman HS, Friedman AH, Bigner DD, McLendon RE.

J Neuropathol Exp Neurol. 2019 Jan 1;78(1):57-64. doi: 10.1093/jnen/nly110.

PMID:
30500933
12.

Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.

Suryadevara CM, Desai R, Farber SH, Choi BD, Swartz AM, Shen SH, Gedeon PC, Snyder DJ, Herndon JE 2nd, Healy P, Reap EA, Archer GE, Fecci PE, Sampson JH, Sanchez-Perez L.

Clin Cancer Res. 2019 Jan 1;25(1):358-368. doi: 10.1158/1078-0432.CCR-18-1211. Epub 2018 Nov 13.

PMID:
30425092
13.

Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma.

Affronti ML, Randazzo D, Lipp ES, Peters KB, Herndon SC, Woodring S, Healy P, Cone CK, Herndon JE 2nd, Schneider SM.

Semin Oncol Nurs. 2018 Dec;34(5):472-485. doi: 10.1016/j.soncn.2018.10.006. Epub 2018 Nov 6. Review.

PMID:
30409554
14.

Adjunctive perampanel for glioma-associated epilepsy.

Dunn-Pirio AM, Woodring S, Lipp E, Herndon JE 2nd, Healy P, Weant M, Randazzo D, Desjardins A, Friedman HS, Peters KB.

Epilepsy Behav Case Rep. 2018 Oct 9;10:114-117. doi: 10.1016/j.ebcr.2018.09.003. eCollection 2018.

15.

Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking.

Tome ME, Jarvis CK, Schaefer CP, Jacobs LM, Herndon JM, Hunn KC, Arkwright NB, Kellohen KL, Mierau PC, Davis TP.

J Cereb Blood Flow Metab. 2018 Dec;38(12):2209-2222. doi: 10.1177/0271678X18803623. Epub 2018 Oct 22.

PMID:
30346224
16.

The Academic Chair: Achieving Success in a Rapidly Evolving Health-Care Environment: AOA Critical Issues.

Salazar DH, Herndon JH, Vail TP, Zuckerman JD, Gelberman RH.

J Bone Joint Surg Am. 2018 Oct 17;100(20):e133. doi: 10.2106/JBJS.17.01056.

PMID:
30334894
17.

The patient-centered dental home: A standardized definition for quality assessment, improvement, and integration.

Damiano P, Reynolds J, Herndon JB, McKernan S, Kuthy R.

Health Serv Res. 2019 Apr;54(2):446-454. doi: 10.1111/1475-6773.13067. Epub 2018 Oct 10.

PMID:
30306558
18.

Age-related decline in cognitive flexibility in female chimpanzees.

Lacreuse A, Parr L, Chennareddi L, Herndon JG.

Neurobiol Aging. 2018 Dec;72:83-88. doi: 10.1016/j.neurobiolaging.2018.08.018. Epub 2018 Aug 24.

PMID:
30237074
19.

Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors.

Iñiguez-Ariza NM, Kohlenberg JD, Delivanis DA, Hartman RP, Dean DS, Thomas MA, Shah MZ, Herndon J, McKenzie TJ, Arlt W, Young WF Jr, Bancos I.

Mayo Clin Proc Innov Qual Outcomes. 2017 Dec 21;2(1):30-39. doi: 10.1016/j.mayocpiqo.2017.11.002. eCollection 2018 Mar.

20.

Primary adrenal insufficiency due to bilateral infiltrative disease.

Herndon J, Nadeau AM, Davidge-Pitts CJ, Young WF, Bancos I.

Endocrine. 2018 Dec;62(3):721-728. doi: 10.1007/s12020-018-1737-7. Epub 2018 Sep 3.

PMID:
30178435
21.

Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE.

Nat Med. 2018 Sep;24(9):1459-1468. doi: 10.1038/s41591-018-0135-2. Epub 2018 Aug 13. Erratum in: Nat Med. 2019 Mar;25(3):529.

22.

Academic Orthopaedic Leadership: Current Challenges and Lessons Learned: AOA Critical Issues.

Salazar DH, Herndon JH, Vail TP, Zuckerman JD, Gelberman RH.

J Bone Joint Surg Am. 2018 Aug 1;100(15):e103. doi: 10.2106/JBJS.17.01055.

PMID:
30063601
23.

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

Desjardins A, Gromeier M, Herndon JE 2nd, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, McLendon RE, Ashley D, Bigner DD.

N Engl J Med. 2018 Jul 12;379(2):150-161. doi: 10.1056/NEJMoa1716435. Epub 2018 Jun 26.

24.

Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.

Suryadevara CM, Desai R, Abel ML, Riccione KA, Batich KA, Shen SH, Chongsathidkiet P, Gedeon PC, Elsamadicy AA, Snyder DJ, Herndon JE 2nd, Healy P, Archer GE, Choi BD, Fecci PE, Sampson JH, Sanchez-Perez L.

Oncoimmunology. 2018 Feb 21;7(6):e1434464. doi: 10.1080/2162402X.2018.1434464. eCollection 2018.

25.

Distance, elevation and environment as drivers of diversity and divergence in bumble bees across latitude and altitude.

Jackson JM, Pimsler ML, Oyen KJ, Koch-Uhuad JB, Herndon JD, Strange JP, Dillon ME, Lozier JD.

Mol Ecol. 2018 Jul;27(14):2926-2942. doi: 10.1111/mec.14735. Epub 2018 Jun 17.

PMID:
29862596
26.

The clinical importance of medulloblastoma extent of resection: a systematic review.

Thompson EM, Bramall A, Herndon JE 2nd, Taylor MD, Ramaswamy V.

J Neurooncol. 2018 Sep;139(3):523-539. doi: 10.1007/s11060-018-2906-5. Epub 2018 May 23. Review.

PMID:
29796724
27.

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.

Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy PN, Herndon JE 2nd, McLendon RE, Keir ST, Archer GE, Reap EA, Sanchez-Perez L, Bigner DD, Sampson JH.

Clin Cancer Res. 2018 Aug 1;24(15):3611-3631. doi: 10.1158/1078-0432.CCR-17-0126. Epub 2018 Apr 27.

28.

Mission of Mercy patient characteristics and dental-related emergency department use.

Paramore JO, Herndon JB, Brown AB.

J Am Dent Assoc. 2018 May;149(5):336-347.e3. doi: 10.1016/j.adaj.2017.11.029.

PMID:
29703278
29.

Exogenous fatty acids alter phospholipid composition, membrane permeability, capacity for biofilm formation, and antimicrobial peptide susceptibility in Klebsiella pneumoniae.

Hobby CR, Herndon JL, Morrow CA, Peters RE, Symes SJK, Giles DK.

Microbiologyopen. 2019 Feb;8(2):e00635. doi: 10.1002/mbo3.635. Epub 2018 Apr 27.

30.

Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.

Affronti ML, Jackman JG, McSherry F, Herndon JE 2nd, Massey EC Jr, Lipp E, Desjardins A, Friedman HS, Vlahovic G, Vredenburgh J, Peters KB.

Oncologist. 2018 Aug;23(8):889-e98. doi: 10.1634/theoncologist.2018-0149. Epub 2018 Apr 17.

31.

Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial.

Scott JM, Iyengar NM, Nilsen TS, Michalski M, Thomas SM, Herndon J 2nd, Sasso J, Yu A, Chandarlapaty S, Dang CT, Comen EA, Dickler MN, Peppercorn JM, Jones LW.

Cancer. 2018 Jun 15;124(12):2552-2560. doi: 10.1002/cncr.31368. Epub 2018 Apr 6.

32.

Novel Methods for Reporting of Exercise Dose and Adherence: An Exploratory Analysis.

Nilsen TS, Scott JM, Michalski M, Capaci C, Thomas S, Herndon JE 2nd, Sasso J, Eves ND, Jones LW.

Med Sci Sports Exerc. 2018 Jun;50(6):1134-1141. doi: 10.1249/MSS.0000000000001545.

33.

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

Peters KB, Lipp ES, Miller E, Herndon JE 2nd, McSherry F, Desjardins A, Reardon DA, Friedman HS.

J Neurooncol. 2018 Apr;137(2):349-356. doi: 10.1007/s11060-017-2724-1. Epub 2017 Dec 21.

PMID:
29264836
34.

Single fraction stereotactic radiosurgery for multiple brain metastases.

Limon D, McSherry F, Herndon J, Sampson J, Fecci P, Adamson J, Wang Z, Yin FF, Floyd S, Kirkpatrick J, Kim GJ.

Adv Radiat Oncol. 2017 Sep 11;2(4):555-563. doi: 10.1016/j.adro.2017.09.002. eCollection 2017 Oct-Dec.

35.

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma.

Ghiaseddin A, Reardon D, Massey W, Mannerino A, Lipp ES, Herndon JE 2nd, McSherry F, Desjardins A, Randazzo D, Friedman HS, Peters KB.

Oncologist. 2018 Feb;23(2):157-e21. doi: 10.1634/theoncologist.2017-0501. Epub 2017 Nov 13.

36.

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.

Reap EA, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE 2nd, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, Hossain-Ibrahim MK, Saraswathula A, Nair SK, Dunn-Pirio AM, Broome TM, Weinhold KJ, Desjardins A, Vlahovic G, McLendon RE, Friedman AH, Friedman HS, Bigner DD, Fecci PE, Mitchell DA, Sampson JH.

Cancer Res. 2018 Jan 1;78(1):256-264. doi: 10.1158/0008-5472.CAN-17-0469. Epub 2017 Nov 1.

37.

Developing a caries risk registry to support caries risk assessment and management for children: A quality improvement initiative.

Ruff JC, Herndon JB, Horton RA, Lynch J, Mathwig DC, Leonard A, Aravamudhan K.

J Public Health Dent. 2018 Mar;78(2):134-143. doi: 10.1111/jphd.12253. Epub 2017 Oct 27.

PMID:
29077195
38.

Exogenous polyunsaturated fatty acids (PUFAs) alter phospholipid composition, membrane permeability, biofilm formation and motility in Acinetobacter baumannii.

Eder AE, Munir SA, Hobby CR, Anderson DM, Herndon JL, Siv AW, Symes SJK, Giles DK.

Microbiology. 2017 Nov;163(11):1626-1636. doi: 10.1099/mic.0.000556. Epub 2017 Oct 23.

PMID:
29058654
39.
40.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Sep 19;47(3):597. doi: 10.1016/j.immuni.2017.08.018. No abstract available.

41.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Aug 15;47(2):323-338.e6. doi: 10.1016/j.immuni.2017.07.014. Erratum in: Immunity. 2017 Sep 19;47(3):597.

42.

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.

Randazzo DM, McSherry F, Herndon JE 2nd, Affronti ML, Lipp ES, Flahiff C, Miller E, Woodring S, Freeman M, Healy P, Minchew J, Boulton S, Desjardins A, Vlahovic G, Friedman HS, Keir S, Peters KB.

J Neurooncol. 2017 Sep;134(2):363-369. doi: 10.1007/s11060-017-2535-4. Epub 2017 Jul 1.

PMID:
28669010
43.

The Association of Health Literacy With Preventable Emergency Department Visits: A Cross-sectional Study.

Balakrishnan MP, Herndon JB, Zhang J, Payton T, Shuster J, Carden DL.

Acad Emerg Med. 2017 Sep;24(9):1042-1050. doi: 10.1111/acem.13244. Epub 2017 Aug 14.

44.

Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.

Zhang X, Kim S, Hundal J, Herndon JM, Li S, Petti AA, Soysal SD, Li L, McLellan MD, Hoog J, Primeau T, Myers N, Vickery TL, Sturmoski M, Hagemann IS, Miller CA, Ellis MJ, Mardis ER, Hansen T, Fleming TP, Goedegebuure SP, Gillanders WE.

Cancer Immunol Res. 2017 Jul;5(7):516-523. doi: 10.1158/2326-6066.CIR-16-0264. Epub 2017 Jun 15.

45.

Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.

Narloch JL, Farber SH, Sammons S, McSherry F, Herndon JE, Hoang JK, Yin FF, Sampson JH, Fecci PE, Blackwell KL, Kirkpatrick JP, Kim GJ.

Neuro Oncol. 2017 Oct 1;19(10):1391-1397. doi: 10.1093/neuonc/nox090.

46.

Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.

Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH.

Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057.

47.

Measuring quality: caries-related emergency department visits and follow-up among children.

Herndon JB, Crall JJ, Carden DL, Catalanotto FA, Tomar SL, Aravamudhan K, Light JK, Shenkman EA.

J Public Health Dent. 2017 Jun;77(3):252-262. doi: 10.1111/jphd.12206. Epub 2017 Mar 2.

PMID:
28252806
48.

Rethinking Autoantibody Signature Panels for Cancer Diagnosis.

Campa MJ, Gottlin EB, Herndon JE 2nd, Patz EF Jr.

J Thorac Oncol. 2017 Jun;12(6):1011-1014. doi: 10.1016/j.jtho.2017.01.017. Epub 2017 Jan 23.

49.

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab.

Affronti ML, Woodring S, Peters KB, Herndon JE 2nd, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS.

Ther Clin Risk Manag. 2016 Dec 23;13:33-40. doi: 10.2147/TCRM.S122480. eCollection 2017.

50.

Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.

Kelley MJ, Jha G, Shoemaker D, Herndon JE 2nd, Gu L, Barry WT, Crawford J, Ready N.

Cancer Invest. 2017 Jan 2;35(1):32-35. doi: 10.1080/07357907.2016.1253710. Epub 2016 Dec 2.

PMID:
27911119

Supplemental Content

Loading ...
Support Center